Fifth Third Bancorp’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $164K | Buy |
11,722
+11,500
| +5,180% | +$155K | ﹤0.01% | 2653 |
|
|
2025
Q4 | $2.49K | Sell |
222
-2
| -0.9% | -$23 | ﹤0.01% | 2409 |
|
|
2025
Q3 | $2.59K | Sell |
224
-45
| -17% | -$527 | ﹤0.01% | 2433 |
|
|
2025
Q2 | $3.29K | Buy |
269
+114
| +74% | +$1.43K | ﹤0.01% | 2282 |
|
|
2025
Q1 | $2.22K | Sell |
155
-175
| -53% | -$2.73K | ﹤0.01% | 2333 |
|
|
2024
Q4 | $5.25K | Buy |
330
+67
| +25% | +$1.33K | ﹤0.01% | 2153 |
|
|
2024
Q3 | $6.32K | Buy |
263
+43
| +20% | +$983 | ﹤0.01% | 2121 |
|
|
2024
Q2 | $4.38K | Buy |
220
+90
| +69% | +$1.75K | ﹤0.01% | 2152 |
|
|
2024
Q1 | $2.59K | Sell |
130
-19
| -13% | -$367 | ﹤0.01% | 2190 |
|
|
2023
Q4 | $3.34K | Sell |
149
-236
| -61% | -$4.87K | ﹤0.01% | 2276 |
|
|
2023
Q3 | $7.79K | Buy |
385
+211
| +121% | +$4.78K | ﹤0.01% | 2041 |
|
|
2023
Q2 | $4.45K | Sell |
174
-74
| -30% | -$1.95K | ﹤0.01% | 2231 |
|
|
2023
Q1 | $7.38K | Buy |
248
+56
| +29% | +$1.63K | ﹤0.01% | 2203 |
|
|
2022
Q4 | $5.2K | Buy |
192
+19
| +11% | +$465 | ﹤0.01% | 2194 |
|
|
2022
Q3 | $4K | Buy |
+173
| New | +$4.52K | ﹤0.01% | 2221 |
|
|
2022
Q2 | – | Sell |
-301
| Closed | -$10K | – | 2641 |
|
|
2022
Q1 | $10K | Sell |
301
-140
| -32% | -$4.51K | ﹤0.01% | 2042 |
|
|
2021
Q4 | $15K | Buy |
441
+348
| +374% | +$11.3K | ﹤0.01% | 1951 |
|
|
2021
Q3 | $3K | Buy |
93
+61
| +191% | +$2.07K | ﹤0.01% | 2317 |
|
|
2021
Q2 | $1K | Sell |
32
-265
| -89% | -$11K | ﹤0.01% | 2371 |
|
|
2021
Q1 | $13K | Buy |
297
+167
| +128% | +$7.84K | ﹤0.01% | 1921 |
|
|
2020
Q4 | $6K | Buy |
130
+35
| +37% | +$1.46K | ﹤0.01% | 2061 |
|
|
2020
Q3 | $3K | Sell |
95
-206
| -68% | -$6.58K | ﹤0.01% | 1954 |
|
|
2020
Q2 | $9K | Sell |
301
-3
| -1% | -$87 | ﹤0.01% | 1752 |
|
|
2020
Q1 | $8K | Buy |
304
+9
| +3% | +$269 | ﹤0.01% | 1769 |
|
|
2019
Q4 | $10K | Buy |
295
+95
| +48% | +$3.44K | ﹤0.01% | 1832 |
|
|
2019
Q3 | $7K | Hold |
200
| – | – | ﹤0.01% | 1865 |
|
|
2019
Q2 | $9K | Hold |
200
| – | – | ﹤0.01% | 1838 |
|
|
2019
Q1 | $9K | Sell |
200
-33
| -14% | -$1.48K | ﹤0.01% | 1795 |
|
|
2018
Q4 | $10K | Buy |
233
+21
| +10% | +$1.1K | ﹤0.01% | 1766 |
|
|
2018
Q3 | $15K | Sell |
212
-36
| -15% | -$2.32K | ﹤0.01% | 1716 |
|
|
2018
Q2 | $14K | Sell |
248
-303
| -55% | -$16K | ﹤0.01% | 1773 |
|
|
2018
Q1 | $25K | Sell |
551
-47
| -8% | -$2.23K | ﹤0.01% | 1569 |
|
|
2017
Q4 | $28K | Buy |
598
+10
| +2% | +$460 | ﹤0.01% | 1478 |
|
|
2017
Q3 | $26K | Buy |
588
+31
| +6% | +$1.32K | ﹤0.01% | 1508 |
|
|
2017
Q2 | $22K | Hold |
557
| – | – | ﹤0.01% | 1521 |
|
|
2017
Q1 | $21K | Sell |
557
-62
| -10% | -$2.42K | ﹤0.01% | 1551 |
|
|
2016
Q4 | $23K | Sell |
619
-168
| -21% | -$6K | ﹤0.01% | 1570 |
|
|
2016
Q3 | $27K | Sell |
787
-345
| -30% | -$12.1K | ﹤0.01% | 1522 |
|
|
2016
Q2 | $37K | Sell |
1,132
-1,890
| -63% | -$57.9K | ﹤0.01% | 1389 |
|
|
2016
Q1 | $87K | Buy |
3,022
+900
| +42% | +$24K | ﹤0.01% | 1133 |
|
|
2015
Q4 | $71K | Buy |
2,122
+463
| +28% | +$14.4K | ﹤0.01% | 1262 |
|
|
2015
Q3 | $47K | Sell |
1,659
-1,140
| -41% | -$39.8K | ﹤0.01% | 1424 |
|
|
2015
Q2 | $113K | Buy |
2,799
+4
| +0.1% | +$180 | ﹤0.01% | 1157 |
|
|
2015
Q1 | $138K | Sell |
2,795
-2,737
| -49% | -$127K | ﹤0.01% | 1084 |
|
|
2014
Q4 | $252K | Buy |
+5,532
| New | +$217K | ﹤0.01% | 902 |
|
Other funds holding AVNS
AC
VCM
VPM
Fifth Third Bancorp's AVNS Position: Q1 2026 in Review
Fifth Third Bancorp increased its Avanos Medical (AVNS) stake by 5,180% in Q1 2026, buying an estimated $155K and bringing the position to 11,722 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2653.
Fifth Third Bancorp first reported a position in AVNS in Q4 2014 and has held it in 45 quarters since. The position peaked at $252K in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Fifth Third Bancorp held 11,722 shares of Avanos Medical worth $164K as of Q1 2026.
- Fifth Third Bancorp bought 11,500 Avanos Medical shares in Q1 2026, an estimated $155K.
- Avanos Medical made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #2653 holding.
- Fifth Third Bancorp first reported a position in Avanos Medical in Q4 2014 and has held it in 45 quarters since.
- Fifth Third Bancorp's Avanos Medical position peaked at $252K in Q4 2014.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.